Birchview Capital, LP
- SEC CIK
- 0001618205
- Latest filing
- Aug 14, 2026
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 10, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 62
- +8 vs. Q1 2021
- Portfolio value
- $167.2M
- −$1.27M (−0.8%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BMYBristol Myers Squibb Co | Stock | 796,106 | $53.2M | 31.8% | +1,920+0.2% | Added | History |
| AXDXAccelerate Diagnostics, Inc | COM | 2,232,857 | $18.0M | 10.7% | +19,531+0.9% | Added | History |
| BDSXBiodesix Inc | COM | 1,104,953 | $14.6M | 8.7% | 00.0% | Unchanged | History |
| NBIXNeurocrine Biosciences Inc | Stock | 80,200 | $7.80M | 4.7% | 00.0% | Unchanged | History |
| QDELQuidelOrtho Corp | COM | 59,684 | $7.65M | 4.6% | +1,040+1.8% | Added | History |
| ACADAcadia Pharmaceuticals Inc | COM | 199,400 | $4.86M | 2.9% | +22,400+12.7% | Added | History |
| BIIBBiogen Inc. | COM | 12,100 | $4.19M | 2.5% | 00.0% | Unchanged | History |
| ALBOAlbireo Pharma, Inc. | COM | 111,000 | $3.90M | 2.3% | 00.0% | Unchanged | History |
| FHTXFoghorn Therapeutics Inc. | COM | 314,143 | $3.35M | 2.0% | 00.0% | Unchanged | History |
| UTHRUnited Therapeutics Corp | COM | 18,000 | $3.23M | 1.9% | 00.0% | Unchanged | History |
| KPTIKaryopharm Therapeutics Inc. | COM | 230,000 | $2.37M | 1.4% | 00.0% | Unchanged | History |
| BLUEbluebird bio, Inc. | COM | 74,000 | $2.37M | 1.4% | −1,500−2.0% | Reduced | History |
| XLRNAcceleron Pharma Inc | COM | 18,672 | $2.34M | 1.4% | 00.0% | Unchanged | History |
| MASIMasimo Corp | COM | 8,000 | $1.94M | 1.2% | 00.0% | Unchanged | History |
| ELTXElicio Therapeutics, Inc. | COM | 60,615 | $1.94M | 1.2% | 00.0% | Unchanged | History |
| VNDAVanda Pharmaceuticals Inc. | COM | 80,000 | $1.72M | 1.0% | 00.0% | Unchanged | History |
| HROWHarrow, Inc. | COM | 180,000 | $1.67M | 1.0% | 00.0% | Unchanged | History |
| PRTAProthena Corp Public Ltd Co | SHS | 30,247 | $1.55M | 0.9% | +30,247 | New | History |
| ARNAArena Pharmaceuticals Inc | COM NEW | 22,000 | $1.50M | 0.9% | 00.0% | Unchanged | History |
| CLRContinental Resources, Inc | COM | 38,600 | $1.47M | 0.9% | 00.0% | Unchanged | History |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 300,000 | $1.31M | 0.8% | 00.0% | Unchanged | History |
| IMGNImmunoGen, Inc. | COM | 190,000 | $1.25M | 0.7% | 00.0% | Unchanged | History |
| NKTRNektar Therapeutics | COM | 72,000 | $1.24M | 0.7% | −20,000−21.7% | Reduced | History |
| ALKSAlkermes plc. | SHS | 50,000 | $1.23M | 0.7% | +15,000+42.9% | Added | History |
| CGEMCullinan Therapeutics, Inc. | COM | 45,114 | $1.16M | 0.7% | −15,000−25.0% | Reduced | History |
| ARVNArvinas, Inc. | COM | 15,000 | $1.16M | 0.7% | 00.0% | Unchanged | History |
| ETRNMidstream Co LLC | COM | 133,050 | $1.13M | 0.7% | 00.0% | Unchanged | History |
| CORTCorcept Therapeutics Inc | COM | 50,000 | $1.10M | 0.7% | 00.0% | Unchanged | History |
| OVVOvintiv Inc. | COM | 34,200 | $1.08M | 0.6% | −150−0.4% | Reduced | History |
| SLNOSoleno Therapeutics Inc | COM | 876,899 | $1.00M | 0.6% | 00.0% | Unchanged | History |
| BHVNBiohaven Ltd. | COM | 10,000 | $971.0K | 0.6% | 00.0% | Unchanged | History |
| BIORBiora Therapeutics, Inc. | COM | 270,000 | $964.0K | 0.6% | 00.0% | Unchanged | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 40,000 | $958.0K | 0.6% | 00.0% | Unchanged | History |
| PGNYProgyny, Inc. | COM | 15,000 | $885.0K | 0.5% | 00.0% | Unchanged | History |
| CFRXCONTRAFECT Corp | COM | 200,000 | $880.0K | 0.5% | 00.0% | Unchanged | History |
| GTHXG1 Therapeutics, Inc. | COM | 40,000 | $878.0K | 0.5% | 00.0% | Unchanged | History |
| Translate Bio, Inc.89374L104 | COM | 30,000 | $826.0K | 0.5% | 00.0% | Unchanged | – |
| NARIInari Medical, Inc. | Stock | 7,000 | $653.0K | 0.4% | 00.0% | Unchanged | History |
| TPTXTurning Point Therapeutics, Inc. | COM | 8,000 | $624.0K | 0.4% | +8,000 | New | History |
| PXDPioneer Natural Resources Co | COM | 3,800 | $618.0K | 0.4% | 00.0% | Unchanged | History |
| TGTXTG Therapeutics, Inc. | COM | 15,000 | $582.0K | 0.3% | 00.0% | Unchanged | History |
| AWHLAspira Women's Health Inc. | COM | 103,104 | $579.0K | 0.3% | 00.0% | Unchanged | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 8,000 | $506.0K | 0.3% | 00.0% | Unchanged | History |
| STOKStoke Therapeutics, Inc. | COM | 15,000 | $505.0K | 0.3% | 00.0% | Unchanged | History |
| PTGXProtagonist Therapeutics, Inc | COM | 10,000 | $449.0K | 0.3% | 00.0% | Unchanged | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 8,000 | $426.0K | 0.3% | +8,000 | New | History |
| XNCRXencor Inc | COM | 12,300 | $424.0K | 0.3% | 00.0% | Unchanged | History |
| LSFLaird Superfood, Inc. | COM STK | 14,000 | $418.0K | 0.3% | 00.0% | Unchanged | History |
| ChemoCentryx, Inc.16383L106 | COM | 30,000 | $402.0K | 0.2% | 00.0% | Unchanged | – |
| AKBAAkebia Therapeutics, Inc. | COM | 100,000 | $379.0K | 0.2% | +100,000 | New | History |
| DRNADicerna Pharmaceuticals Inc | COM | 10,000 | $373.0K | 0.2% | 00.0% | Unchanged | History |
| FOLDAmicus Therapeutics, Inc. | COM | 38,000 | $366.0K | 0.2% | 00.0% | Unchanged | History |
| SIENProject Sage Oldco, Inc. | COM | 40,000 | $318.0K | 0.2% | +40,000 | New | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 20,000 | $316.0K | 0.2% | 00.0% | Unchanged | History |
| ELUTElutia Inc. | CL A COM | 30,000 | $288.0K | 0.2% | +30,000 | New | History |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 20,000 | $279.0K | 0.2% | +20,000 | New | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 9,000 | $246.0K | 0.1% | 00.0% | Unchanged | History |
| IFRXInflaRx N.V. | COM | 70,000 | $208.0K | 0.1% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 10,000 | $198.0K | 0.1% | +10,000 | New | History |
| HOOKHOOKIPA Pharma Inc. | COM | 20,000 | $183.0K | 0.1% | +20,000 | New | History |
| TXMDTherapeuticsMD, Inc. | COM | 100,000 | $119.0K | 0.1% | 00.0% | Unchanged | History |
| CNCEConcert Pharmaceuticals, Inc. | COM | 20,000 | $84.0K | 0.1% | 00.0% | Unchanged | History |
Sold out since Q1 2021 (1)
Positions held at the end of Q1 2021 that are gone from this filing.